Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Small cell lung carcinoma to the conditions list and included a Genetic and Rare Diseases Information Center resource entry.
    Difference
    0.1%
    Check dated 2026-04-02T15:30:41.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and the previous revision v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:49:14.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision notes updated: added Revision: v3.4.3 and removed Revision: v3.4.2. These are backend/versioning updates and do not change the study details or user-facing content on the page.
    Difference
    0.0%
    Check dated 2026-03-12T01:44:01.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2 and removes the funding/operating status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:44:46.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A site-wide funding notice was added. The page revision shows version v3.4.1 replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:26:08.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Glossary has been added to the page to help users understand terms used in the study record. The page now shows new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the older variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:17:45.000Z thumbnail image

Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.